BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/22/2024 9:51:56 AM | Browse: 79 | Download: 216
 |
Received |
|
2023-12-21 13:11 |
 |
Peer-Review Started |
|
2023-12-21 13:11 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-01-30 09:42 |
 |
Revised |
|
2024-02-03 12:14 |
 |
Second Decision |
|
2024-03-22 02:43 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-03-22 06:29 |
 |
Articles in Press |
|
2024-03-22 06:29 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-04-10 01:44 |
 |
Publish the Manuscript Online |
|
2024-04-22 09:51 |
ISSN |
2218-4333 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Minireviews |
Article Title |
Britanin – a beacon of hope against gastrointestinal tumors?
|
Manuscript Source |
Invited Manuscript |
All Author List |
Agnieszka Kajdanek, Damian Kołat, Lin-Yong Zhao, Mateusz Kciuk, Zbigniew Pasieka and Żaneta Kałuzińska-Kołat |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Żaneta Kałuzińska-Kołat, BSc, MSc, Research Assistant, Teaching Assistant, Department of Biomedicine and Experimental Surgery, Medical University of Lodz, Narutowicza 60, Lodz 90-136, Lodzkie, Poland. zaneta.kaluzinska@umed.lodz.pl |
Key Words |
Britanin; Sesquiterpene lactones; Chemotherapeutics; Gastrointestinal tumors; In vitro; In vivo |
Core Tip |
Natural compounds have settled in the development of novel drugs. Britanin is a sesquiterpene lactone whose effect on gastrointestinal tumors has not been summarized before. Our paper reviews the current state of knowledge and proposes novel research directions. Britanin was found to counteract liver, colorectal, pancreatic, and gastric tumors via the regulation of proliferation, apoptosis, autophagy, immune response, migration, and angiogenesis. Future research should examine the link between Britanin and acetylcholinesterase, mast cells, osteolysis, and ischemia. The compound holds promise as an anti-cancer agent and may overcome the paucity of treatment options or high mortality rate in gastrointestinal tumors. |
Publish Date |
2024-04-22 09:51 |
Citation |
Kajdanek A, Kołat D, Zhao LY, Kciuk M, Pasieka Z, Kałuzińska-Kołat Ż. Britanin – a beacon of hope against gastrointestinal tumors? World J Clin Oncol 2024; 15(4): 523-530 |
URL |
https://www.wjgnet.com/2218-4333/full/v15/i4/523.htm |
DOI |
https://dx.doi.org/10.5306/wjco.v15.i4.523 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345